Event Overview

In the increasingly cost-contained world of medical device market access, Payers (including ministries of health, insurers private & public, hospitals and local governments) are seeking to justify investment in new medical technologies. Health Technology Assessment (HTA) agencies are now widely spreads across Europe assess new technologies and interventions not only on the grounds of clinical effectiveness, but also based on cost-effectiveness, cost-utility and cost-benefit, to ensure the payers’ limited funds are well invested. This HTA and value demonstration requirement has evolved the “commercialisation” landscape of medical devices across the world and this next barrier is one that all medical device companies seeking to gain reimbursement and approval from payers and tendering bodies, need to overcome.

The variety of commercial channels, customers and payers within the medical device space is as diverse as the different business models being used for the different product types (e.g. Imaging Vs Surgical products) and only increases the complexity and specificity of the “value message” which needs to well-delivered, in order to ensure an optimal outcome. This three-day event is the “must-attend” event for all senior directors at medical device companies who are looking to enhance market access for their products. We look forward to meeting you in Berlin!

Speakers List

PAYERS, HTA AGENCIES & POLICY MAKERS

Deputy Institute Director
Institute for Quality and Efficiency in Health Care (IQWiG), Germany

Legal & Policy Officer
European Commission

Vice President - Strategic Procurement and Supply of Pharmaceuticals and Medical devices
Amgros, Procurement Service for Regional Authorities, Denmark

Senior Scientific Adviser
NICE - National Institute for Health and Care, UK

Director
Health Technology Wales, UK

Scientific Adviser
RIZIV-INAMI, Belgium

Head of service
Healthcare-associated infections & antimicrobial resistance (Sciensano), Belgium

Scientific Coordinator, Agenas HTA Projects
Agenas (Agency for Regional Health Services), Italy

Head of Clinical Engineering Service
Humanitas Research Hospital, Italy

Former Chief Innovation Officer
America’s Health Insurance Plans (AHIP), USA

Health Economist
Hospital Clinic of Barcelona

Industry Experts

Head Global Market Access & Health Policy, Roche Diagnostics International
Chair “VODI (Value of Diagnostic Information)” WG & HTA for IVD WG, Medtech Europe

Senior Director, Global Health Economics & Reimbursement
Edwards Lifesciences, USA

Vice President International Access, Policy & Advocacy
Myriad, Germany

Vice President, Global Reimbursement & Market Access
Second Sight Medical Products, USA

Senior Director, Head of Health Economics, Market Access & Policy Affairs Europe, Middle-East and Africa
Fresenius Medical Care, Germany

Senior Director, Health Economics & Payment Policy
Stryker, USA

Director, Government Affairs and Access Policy EMEA, Canada & LATAM
Edwards Lifesciences, France

Director, Global Market Access
Intuitive Surgical, USA

Director, Market Access & Economic Policies
MedTech Europe, Belgium

Director, Government Affairs, Policy & Health Economics
GE Healthcare, Italy

(TBC)

Vice-President Market Access and Commercial Excellence
Merit Medical Systems, Netherlands

Director Payers & Health Economics
Coloplast, Germany

Director, Market Access – EMEA
Teleflex, Belgium

Senior Manager in Health Economics, Market Access & Policy Affairs
Fresenius Medical Care, Germany

Head of Health Economics and Healthcare Management Division, Kozminski University
Principal Senior Consultant, Global Market Access, Straub Medical, Switzerland

Market and Business Insights Manager Europe and Canada
Smith & Nephew, Switzerland

Reimbursement Manager, Cardiac Management Solutions
Zoll, Germany

 

Senior Health Economics Manager
Arthrex, Denmark

General Manager
Alifax, Italy

CEO
Oxford Endovascular

Secretary General
EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs, Belgium

Hospital Economics - Sr. Manager Strategic Marketing  Monitoring & Analytics and Therapeutic Care
Philips, Germany

Experienced Solution Provider

Managing Director
ValueConnected

Principal and Founder
Hull Associates, USA

Founder & CEO
MTRC – European Med Tech and IVD Reimbursement Consulting

Head of MedTech Consulting
Huron Consulting Group

Event Structure

Photo Gallery

Event Overview

MedTech: International Payer & HTA Forum

Day 1 - 3rd December, 2019

Stream Overview

Global healthcare systems are evolving daily. At a time of increased health economic reform, ageing populations and budget austerity, leaders in medical technology look to achieve optimal market access and commercialization of their products. As payers worldwide demand more value for money on the medical devices they fund, the importance of achieving patient access by demonstrating cost effectiveness and enhanced health outcomes is of the utmost importance. With payers in both developed and developing countries under extreme budgetary pressure, we will provide a platform for attendees to examine how health technologies are assessed, tough decisions are made and how we define “value”. This exclusive forum is the opportunity to meet and network with a broad spectrum of senior representatives who wish to encourage innovation whilst managing a limited budget.

Speakers

Deputy Institute Director
Institute for Quality and Efficiency in Health Care (IQWiG), Germany

Senior Scientific Adviser
NICE - National Institute for Health and Care, UK

Scientific Adviser
RIZIV-INAMI, Belgium

Scientific Coordinator, Agenas HTA Projects
Agenas (Agency for Regional Health Services), Italy

Head of Clinical Engineering Service
Humanitas Research Hospital, Italy

Managing Director
ValueConnected

Principal and Founder
Hull Associates, USA

Head of MedTech Consulting
Huron Consulting Group

19.00 Networking Dinner

MedTech: Access through HTA Pathways

Day 2 - Stream 1 - 4th December, 2019

Stream Overview

Medical device firms are increasingly under pressure from payers, HTA agencies, healthcare providers and other stakeholders to provide real evidence of their product’s benefit. Increasingly, especially when a technology is expensive, the CE Mark alone is no longer sufficient to gain market access. Robust health economic evidence demonstrating the clinical and economic value of a device is either becoming mandatory, or at least can be a source or competitive advantage to differentiate apparently similar products. Evidence can still be generated from scientific publications, but on top of this, sophisticated and expensive clinical trials and even real-world studies are now being designed and implemented. Getting the trial design right from the beginning is essential, so that the right research questions are being asked and robust methodologies are used to demonstrate improved health outcomes. Protocols must also be operationally feasible to ensure not just messy data is developed, but real evidence so that payers can gain insights into the value and make better reimbursement decisions. This stream will detail  how clinical, real-world, economic and scientific publication data sources can be integrated to prepare a sophisticated value dossier to demonstrate value to payers and other key stakeholders.

 

Speakers

Director
Health Technology Wales, UK

Senior Director, Health Economics & Payment Policy
Stryker, USA

Director, Global Market Access
Intuitive Surgical, USA

Director, Market Access – EMEA
Teleflex, Belgium

Senior Manager in Health Economics, Market Access & Policy Affairs
Fresenius Medical Care, Germany

Reimbursement Manager, Cardiac Management Solutions
Zoll, Germany

 

Senior Health Economics Manager
Arthrex, Denmark

CEO
Oxford Endovascular

MedTech: Procurement & Tendering Excellence

Day 2 - Stream 2 - 4th December, 2019

Stream Overview

Medical devices are coming under greater scrutiny by payers and hospital procurement directors than ever before. Manufacturers today are required to understand and quantify the cost savings for hospitals & payers based on the direct & indirect savings their products deliver. Changes to the European directives on public procurement are directly impacting the way medical device companies communicate and market their products via public procurement channels for high-value products. This one-day event will bring together procurement experts from European Policy-level, leading industry associations, hospitals (procurers) and the MedTech industry to join the conversation and to understand better the needs of their strategic partners. It will enable all participants the opportunity to benchmark procurement processes and tender approaches at a regional, local and hospital perspective. Medical device companies will understand in greater detail what their customers are looking for as drivers of value, and what is attractive for them to enhance their tender and public procurement strategy.

 

Speakers

Former Chief Innovation Officer
America’s Health Insurance Plans (AHIP), USA

Senior Director, Global Health Economics & Reimbursement
Edwards Lifesciences, USA

Director, Market Access & Economic Policies
MedTech Europe, Belgium

Director, Government Affairs, Policy & Health Economics
GE Healthcare, Italy

(TBC)

Vice-President Market Access and Commercial Excellence
Merit Medical Systems, Netherlands

Director Payers & Health Economics
Coloplast, Germany

Market and Business Insights Manager Europe and Canada
Smith & Nephew, Switzerland

Hospital Economics - Sr. Manager Strategic Marketing  Monitoring & Analytics and Therapeutic Care
Philips, Germany

Market Access for Molecular Diagnostics

Day 3 - Stream A (AM) - 5th December, 2019

Stream Overview

Speakers

Head of service
Healthcare-associated infections & antimicrobial resistance (Sciensano), Belgium

Head Global Market Access & Health Policy, Roche Diagnostics International
Chair “VODI (Value of Diagnostic Information)” WG & HTA for IVD WG, Medtech Europe

Vice President International Access, Policy & Advocacy
Myriad, Germany

General Manager
Alifax, Italy

Secretary General
EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs, Belgium

MedTech: Key Market Briefs – EU Big 5

Day 3 - Stream B (AM) - 5th December, 2019

Stream Overview

Speakers

Director, Government Affairs and Access Policy EMEA, Canada & LATAM
Edwards Lifesciences, France

Founder & CEO
MTRC – European Med Tech and IVD Reimbursement Consulting

MedTech: Market Access for Digital Interventions & SAAMD

Day 3 - (PM) - 5th December, 2019

Stream Overview

Connected Healthcare is now a reality, as well as Digital Interventions and Software as a Medical Device (SaaMD). “Digital patients” are increasingly being “connected” to the IoMT ecosystem through digitally-enabled devices, their mobile phones and electronic health records data. There is a treasure trove of information out there from a multitude of sources which promise both exciting opportunities and daunting challenges. Not surprisingly, physicians are now starting to see the clinical value of such technologies and payers increasingly realise there can be great health economic benefits worth paying for, yet they are extremely difficult to define, measure and value.

This unique event will discuss:

  1. How to define and demonstrate the real economic value of Digital interventions and SaaMD techs
  2. What are the business models for medtech companies with unique digital applications
  3. What are the reimbursement possibilities and models for apps as either stand-alone techs or bundled with a medical device

Speakers

Head Global Market Access & Health Policy, Roche Diagnostics International
Chair “VODI (Value of Diagnostic Information)” WG & HTA for IVD WG, Medtech Europe

Vice President, Global Reimbursement & Market Access
Second Sight Medical Products, USA

Head of Health Economics and Healthcare Management Division, Kozminski University
Principal Senior Consultant, Global Market Access, Straub Medical, Switzerland

Medical Device & Diagnostic Companies: Market Access, Health Economics, Pricing & Reimbursement, Strategic Marketing, Payer Relations, Value Strategy, Business Development, Country Managers, , Government & Stakeholder Relations, Regulatory Affairs

External Stakeholders: Health Plans & Insurers, Payers, Health Technology Assessors, Hospitals, Health Ministry, Regulatory Agencies, Independent Health Economists, Academics, Physicians and Patient Groups

Solution providers & consultants: CEOs, Business Development, Senior Consultants, Global and Regional Heads, Independent Academics, Health Economists

Event Partners

Media Partners

This event is accredited for CPD (Continuing Professional Development) status

RECEIVE DISCOUNTED FLIGHTS WHEN YOU REGISTER FOR THIS EVENT WITH

Page part title: Previous Attendees at MedTech Access Leaders Forum - Berlin, Germany, 2018

Company
Job Title
3M
Commercialization and Market Access Lead EMEA
Abbott
Global Market Access Manager, EMEA
Agenas (Agency for Regional Health Services), Italy
Scientific Coordinator, Agenas HTA Projects
Agnitio
Product Marketing Manager
Agnitio
Director, Client Services
AgNovos Healthcare GmbH
Vice President Global Sales
AgNovos Healthcare GmbH
Vice President Global Marketing
Air Liquide Healthcare
Global Market Access Director
Alcon
Market Access Manager, Glaucoma and Vitreoretinal, EMEA
Arjo
Sr. Director Marketing & Academy Europe
BD Medical
Head of Market Access & Pricing, BD Diabetes Care EMEA
Biotronik
Health Economics and Market Access Manager
Biovica International AB
Market Access & QA Director
Boston Healthcare Associates
Director
Boston Healthcare Associates
Manager
Boston Healthcare Associates
Vice President
Boston Healthcare, USA
President
Boston Scientific
Senior Fellow, R&D
Boston Scientific
Sr Manager HEMA EMEA
Boston Scientific International SA
Manager HEMA EMEA
BRAHMS
Manager Health Economics and Pricing
Carl Zeiss
Strategic Marketing & Customer Insights
Center of Healthcare Quality Assessment and Control, The Ministry of Health of the Russian Federation
Chief of development and communications
Cetas Healthcare
Managing Director
Coloplast
Director Payers & Health Economics
Cooper Surgical
European Business Manager
CytoSorbents
Health Economics manager
CytoSorbents
Manager Reimbursement
CytoSorbents Europe
Senior Manager Reimbursement & Health Economics
Erasmus School of Health Policy and Management (ESHPM) Institute for Medical Technology Assessment (iMTA)
Associate Professor, Economic Evaluations in Health Care
European Commission
Legal & Policy Officer
European Commission
Programme Officer European Commission eHealth, Well-being and Ageing (DG Connect)
European Med Tech and IVD Reimbursement Consulting Ltd.
Director
Fresenius Medical Care
Senior Director, Head of Health Economics, Market Access & Policy Affairs, Europe, Middle-East and Africa
Fresenius Medical Care
Health Economics, Market Access and Policy Affairs Central & North Eastern Europe
Fresenius Medical Care
Health Economics, Market Access and Policy Affairs Western Europe
Fresenius Medical Care
Senior Director, Head of Health Economics, Market Access & Policy Affairs EMEA
Fresenius Medical Care
Market Access Expert Italy
Fresenius Medical Care
Product Manager
Fresenius Medical Care
Senior Manager Regional Management, Russian Federation
Fresenius Medical Care
Head of Strategic Initiatives Germany
Fresenius Medical Care
Health Economics, Market Access and Policy Affairs Eastern Europe, Middle-East and Africa
Fresenius Medical Care
Health Economics, Market Access and Policy Affairs - Germany, Austria and Switzerland
Fresenius Medical Care
President Fresenius Poland
Genomic Health Int'l Sarl
Head of Market Access, France and Italy
Glaukos
Market access Director
Health Technology Wales
Senior Health Economist
Hull Associates
Senior Vice President, Europe
Hull Associates
Principal & Founder
Humanitas Research Hospital
Director, Clinical Engineering Service
Huron Consulting
Director, Life Sciences
Impact HTA
Member
Inspire Medical Systems
Vice President, Global Market Access
Institute of Applied Economics & Health Research
Senior Consultant
iThera Medical
CEO
iThera Medical
Marketing Associate
iThera Medical
Business Development Manager
Johnson & Johnson
Market Access Manager
Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA)
Director
Main Association of Austrian Social Insurance Institutions
Head of Department of Economic Evidence-based Health Care
MD squared
Consultant and Owner
MED-EL
Head of Tenders
MED-EL
Head of Reimbursement & HTA
MedTech Economics
Managing Director
MedTech Europe
Manager Market Access and Economic Policies
Medtech4Health
Program Director
Medtronic
Global Scientific Communications Director, Medical Affairs
Medtronic
Vice President, Market Access, Latin America
Merit
Market Access Director
Merit Holdings Inc
VP Market Access and Commercial Excellence
Myriad Genetics GmbH
Chief Commercial Officer, Europe
National Institute for Health and Care Excellence
Senior Scientific Adviser
NHS
Associate Director of Medicines Optimisation, DGS & Swale CCGs
North Star
Director
Ottobock SE & Co. KGaA
Vice President Strategic Marketing Unit Prosthetics Lower Limb
PARI GmbH
Medical Affairs Manager
Philips Healthcare
Senior Manager Hospital Economics
Philips Healthcare
Vice President Research
Philips Healthcare
Global Pricing Manager, PCMS Pricing Team
Qvella Corporation
VP Business Development EMEA
Region Jämtland Härjedalen
Director of Research and Education, Professor in Medical Biophysics
Roche Tissue Diagnostics
Senior Director, Market Access
Roche Diagnostics
Vice President, Head of Global Market Access
Santen
Associate Director Market Access EMEA
Straub Medical
Global Market Access Director
Stryker
Director Clinical Strategy
Stryker
Snr Director Clinical Affairs
ValueConnected
Director of Operations, Europe
ValueConnected
Managing Director
WIMENCO
Senior Consultant
Zoll
Business Development Manager EMEA
Zoll
Strategic Reimbursement Manager

Related Videos

Presentation

Enabling value selling for Surgical & Implantable Devices

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • What is the role of market access in economic selling?
  • The challenge of quantifying value.
  • Building effective tools and training methods.
  • Partnering with commercial teams.
  • Case studies: Selling value in the UK and Germany.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Triggering incremental funding for medical innovations

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • Are traditional reimbursement systems adequate for innovation?
  • Rewarding value, not only cost or evidence
  • Innovative Payment Mechanisms in Europe
  • Implications to Market Access Strategy
Speaker

Ben Modley
Director of European Operations
ValueConnected

View Agenda or Register